Rheumatology Clinical Trials
Delivering quality care through clinical trials
Available clinical trials are below. Click the + sign to expand and review details about their purpose, eligibility criteria, and contact information for study staff. For some studies, you will find a link to ClinicalTrials.gov, where you can explore more information about each study.
Study Phase: Phase II - Drug
Condition(s): Systemic Lupus Erythematosus (SLE)Systemic Lupus Erythematosus (SLE) Treatment with N-acetylcysteine (NAC) (SNAC)
ClinicalTrials.gov NCT ID: NCT00775476
You can view the full clinical description on ClinicalTrials.gov.
View Full DescriptionTo inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.